The Association of Vitamin D Status with Oxidative Stress Biomarkers and Matrix Metalloproteinases in Patients with Knee Osteoarthritis
Overview
Authors
Affiliations
Objective: The association of vitamin D status with osteoarthritis (OA) has been demonstrated previously. The current study was performed to examine the association of vitamin D status with oxidative stress markers and matrix metalloproteinases (MMPs) in patients with knee OA.
Methods: This case-control study was conducted on 124 subjects with mild to moderate knee OA and 65 healthy controls. Demographic data was collected from all participants at baseline. Serum levels of vitamin D as well as markers of oxidative stress including malondialdehyde (MDA), total oxidant status (TOS), superoxide dismutase (SOD), oxidative stress index (OSI), paraoxonase-1 (PON-1), glutathione peroxidase (GPX), catalase (CAT), and total antioxidant capacity (TAC) were evaluated for each participant. Furthermore, serum concentrations of MMP-1, MMP-3, MMP-13, and cartilage oligomeric matrix protein (COMP) were measured.
Results: The results of the present study indicated that individuals with vitamin D insufficiency had higher levels of MDA, TOS, SOD, and OSI as well as lower levels of PON-1 and TAC. Based on the linear regression analysis, serum vitamin D levels were inversely correlated with MDA, TOS, SOD, OSI, MMP-1, and MMP-13 and positively associated with TAC levels ( < 0.0001). Patients with sufficient vitamin D levels had lower MMP-1 and MMP-13 levels compared to patients with vitamin D insufficiency ( < 0.001 and p < 0.001, respectively).
Conclusion: Findings from this study showed a strong association between vitamin D deficiency and increased oxidative stress and MMPs activity in patients with knee OA.
Wang L, Xu R, Wang M, Wang M, Su S, Nian Y Onco Targets Ther. 2025; 18:129-145.
PMID: 39872437 PMC: 11769849. DOI: 10.2147/OTT.S495066.
Wnt5a manipulate the progression of osteoarthritis via MMP-13 dependent signaling pathway.
Minghua S, Jiwei T, Lei Z, Jizhou Q, Zhiyuan L, Jiangang C Medicine (Baltimore). 2024; 103(50):e40676.
PMID: 39686437 PMC: 11651448. DOI: 10.1097/MD.0000000000040676.
Yaribeygi H, Ramezani M, Katsiki N, Mirmohammadkhani M, Tabaei N Curr Ther Res Clin Exp. 2024; 101:100764.
PMID: 39582742 PMC: 11584711. DOI: 10.1016/j.curtheres.2024.100764.
Ammirata G, Arigoni M, Licastro D, Caviglia G, Disabato M, Zubair G Antioxidants (Basel). 2024; 13(9).
PMID: 39334706 PMC: 11429492. DOI: 10.3390/antiox13091047.
Liu L, Zhang B, Zhou Z, Yang J, Li A, Wu Y Drug Des Devel Ther. 2024; 18:1583-1602.
PMID: 38765877 PMC: 11102756. DOI: 10.2147/DDDT.S455006.